During the past decade, University of New Mexico Clinical and Translational Science Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of New Mexico Clinical and Translational Science Center" #1 sponsor was "University of New Mexico" with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Actelion" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of New Mexico Clinical and Translational Science Center" #1 collaborator was "American Diabetes Association" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of New Mexico Clinical and Translational Science Center" are "COVID-19" (4 trials), "Type 2 Diabetes" (2 trials), "Atherosclerosis" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Cystic Fibrosis" (1 trials). Many other conditions were trialed in "University of New Mexico Clinical and Translational Science Center" in a lesser frequency.

Most popular intervention types in "University of New Mexico Clinical and Translational Science Center" are "Drug" (8 trials), "Other" (4 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Remdesivir" (3 trials), "Baricitinib" (2 trials), "Dexamethasone" (1 trials) and "Diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of New Mexico Clinical and Translational Science Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University of New Mexico Clinical and Translational Science Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of New Mexico Clinical and Translational Science Center, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of New Mexico Clinical and Translational Science Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".